Robert Wessman
Robert Wessman is Chairman and CEO of Alvogen, USA.
False
Advertisement
Why Are We Still Waiting for Biosimilars?
April 21, 2017
By applying “common sense,” President Trump has an opportunity to help get the industry moving and make a real mark on US healthcare by boosting biogeneric use.
1 min read
Newsletters
Receive the latest pharmaceutical news, personalities, education, and career development – weekly to your inbox.
